Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Oncogene ; 21(5): 809-24, 2002 Jan 24.
Artigo em Inglês | MEDLINE | ID: mdl-11850809

RESUMO

The mechanism of bFGF-induced cell death in tumours of the Ewing's sarcoma family (ESFT) has been investigated. bFGF-induces phosphorylation of FGFr 1 and activation of Ras/ERK in ESFT cells that die when exposed to bFGF. Induction of cell death was associated with activation of both initiator (caspases-2, -8 and -10) and effector (caspases-3, -6 and -7) caspases. Moreover, the general caspase inhibitor Z-VAD-FMK protected cells from bFGF-induced cell death. After treatment with bFGF, a loss of mitochondrial transmembrane potential was accompanied by down-regulation of Bcl-2. However, the observed cell death was not associated with release of cytochrome c from the mitochondria. Furthermore, expression of wild-type p53 was not required for bFGF-induced cell death. These observations suggest that bFGF-induced cell death may be mediated through a cell death receptor mechanism, supported by up-regulation of the p75 neurotrophin receptor. bFGF-induced cell death was associated with up-regulation of p21 and p53, down-regulation of PCNA and cyclin A and a decrease in active pRb1, changes consistent with accumulation of cells in G1. These data demonstrate that bFGF-induced cell death is effected through a caspase-dependent and p53-independent mechanism, that may be mediated through a cell death receptor pathway.


Assuntos
Neoplasias Ósseas/metabolismo , Caspases/fisiologia , Morte Celular , Fator 2 de Crescimento de Fibroblastos/farmacologia , Sarcoma de Ewing/metabolismo , Animais , Neoplasias Ósseas/patologia , Contagem de Células , Ciclo Celular/efeitos dos fármacos , Linhagem Celular , Humanos , Camundongos , Mitocôndrias/metabolismo , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Fosforilação , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteínas Proto-Oncogênicas p21(ras)/metabolismo , Receptores Proteína Tirosina Quinases/metabolismo , Receptor Tipo 1 de Fator de Crescimento de Fibroblastos , Receptor de Fator de Crescimento Neural , Receptores de Fatores de Crescimento de Fibroblastos/metabolismo , Receptores de Fator de Crescimento Neural/metabolismo , Sarcoma de Ewing/patologia , Transdução de Sinais , Células Tumorais Cultivadas , Proteína Supressora de Tumor p53/fisiologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa